## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no full text, figures, tables, or supplementary materials were provided
- **Shared manuscript claim summary** The authors report the engineering of a de novo six-helical barrel biocatalyst (6H5L) through a combination of AlphaFold2-guided RosettaRemodel and ProteinMPNN sequence redesign. They claim successful design of a truncated variant with crystal structure matching the design model, a tenfold increase in soluble protein yield in *E. coli* for a sequence-redesigned variant, retention of barrel architecture, high thermal stability, and catalytic activity in both purified and whole-cell systems, with altered kinetic parameters (kcat and Km).
- **Visible evidence base** Abstract text only; no experimental details, structural coordinates, kinetic data, or statistical analyses are available
- **Missing materials affecting confidence** Full manuscript, all figures and tables, methods section, supplementary information, crystallographic data, kinetic measurements, and sequence alignments

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting advance in the engineering of de novo α-helical barrel biocatalysts, combining deep learning-based design with classical computational methods. The claims are plausible but cannot be rigorously evaluated from the abstract alone. The key findings, particularly the structural match, yield improvement, and retained catalytic activity, require detailed experimental evidence that is not visible in the supplied material. The work may be of interest to the protein design and biocatalysis communities, but the current evidence base is insufficient to establish the case.
- **Who would be interested in the results, and why** Researchers in de novo protein design, computational enzyme engineering, and biocatalysis would be interested. The demonstration of sequence variability tolerance in a helical barrel scaffold and the use of AlphaFold2-guided design with ProteinMPNN could inform future design strategies. Those working on thermostable biocatalysts for industrial applications may also find the whole-cell activity and soluble yield improvements relevant.
- **Major strengths** The combination of deep learning-based design (AlphaFold2, ProteinMPNN) with classical computational methods (RosettaRemodel) is a modern and potentially powerful approach. The focus on a de novo scaffold with high thermostability and structural simplicity is well motivated. The reported tenfold improvement in soluble yield addresses a practical bottleneck in protein production. The inclusion of whole-cell catalytic activity suggests potential application relevance.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not provide sufficient detail to assess the structural validation, the magnitude and reproducibility of the yield improvement, the quantitative kinetic parameters, or the statistical significance of any comparisons. Without these, the core claims of retained structure, stability, and activity cannot be verified.
- **Assessment against Nature-style criteria** Originality is moderate to high, as the combination of AlphaFold2-guided truncation with ProteinMPNN redesign on a de novo helical barrel is not routine. Scientific importance is potentially significant for the protein design field, but the abstract does not demonstrate a generalizable principle or a major advance beyond existing methods. Interdisciplinary readership is plausible, spanning structural biology, computational design, and biocatalysis, but the abstract is too brief to engage nonspecialists effectively. Technical soundness cannot be assessed from the abstract alone. Readability for nonspecialists is acceptable but limited by the lack of context on the 6H5L scaffold and the design methods.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests promising results, but the absence of experimental details and data prevents a supportive recommendation. A full manuscript with rigorous structural, biophysical, and kinetic analyses would be required to evaluate the claims.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Structural validation
- **Claim pointer** The truncated variant's crystal structure closely matches the design model.
- **Evidence pointer** Abstract text; location not provided
- **Concern** The abstract states that the crystal structure of the truncated variant closely matches the design model, but no quantitative metrics are provided, such as root-mean-square deviation (RMSD) values, percentage of residues within a certain deviation, or comparison of key active-site residues. Without these, the claim of a close match is unverifiable.
- **Why it matters** Structural fidelity is central to the claim that the design approach is successful. A qualitative statement of "closely matches" is insufficient for a rigorous assessment, especially given that the scaffold is de novo and the truncation could introduce unforeseen conformational changes.
- **Resolution test** Provide crystallographic statistics, including resolution, R-factor, and RMSD between the design model and the experimental structure, along with a structural overlay figure. Quantify the deviation in the active-site region and discuss any conformational differences.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Protein production and activity
- **Claim pointer** The sequence-redesigned variant shows a tenfold increase in soluble protein yield in *E. coli* and retains catalytic activity in both purified and whole-cell systems.
- **Evidence pointer** Abstract text; location not provided
- **Concern** The tenfold yield improvement is reported without experimental context, such as the baseline yield, the method of quantification (e.g., SDS-PAGE densitometry, Bradford assay), or the number of replicates. Similarly, the retention of catalytic activity is stated without kinetic parameters or specific activity values, and the whole-cell activity is not quantified. The abstract also notes variation in kcat and Km but does not provide the values or the substrate used.
- **Why it matters** Yield improvements and retained activity are the primary practical outcomes of the engineering. Without quantitative data and statistical analysis, the claims could be based on a single experiment or a nonrepresentative condition, and the kinetic variation could indicate either beneficial or detrimental changes.
- **Resolution test** Provide yield measurements with error bars and statistical tests, a comparison of specific activities or kcat/Km values for the parent and variants, and whole-cell activity data with appropriate controls. Specify the substrate and assay conditions.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Sequence and structural integrity
- **Claim pointer** Both variants retained the overall barrel architecture, high thermal stability, and catalytic activity.
- **Evidence pointer** Abstract text; location not provided
- **Concern** The claim of retained barrel architecture and high thermal stability is based on "biochemical, biophysical, and structural analyses," but no specific methods or results are described. For example, it is unclear whether thermal stability was assessed by circular dichroism melting curves, differential scanning calorimetry, or another method, and what the melting temperatures are. The structural analysis is not detailed beyond the crystal structure of the truncated variant.
- **Why it matters** The central premise of the work is that the scaffold can tolerate large sequence changes while maintaining its properties. Without quantitative stability data and structural characterization of both variants, the claim of retained architecture and stability is not established.
- **Resolution test** Include melting temperature (Tm) values for the parent and both variants, size-exclusion chromatography or multi-angle light scattering data to confirm oligomeric state, and structural characterization (e.g., crystal structure or cryo-EM) for the redesigned variant, not just the truncated one.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity of methods
- **Affected element** Design workflow description
- **Evidence pointer** Abstract text; location not provided
- **Issue** The abstract states that "AlphaFold2-guided RosettaRemodel" was used, but the nature of the guidance is not specified. It is unclear whether AlphaFold2 was used to predict structures of RosettaRemodel outputs, to filter designs, or in some other capacity.
- **Required correction** Clarify the role of AlphaFold2 in the design pipeline, for example, whether it was used for structure prediction, validation, or iterative refinement.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Terminology precision
- **Affected element** "Sequence variability tolerance"
- **Evidence pointer** Abstract title and text; location not provided
- **Issue** The title and abstract emphasize "sequence variability tolerance," but the abstract only describes a single truncation and a single sequence redesign. The term implies a systematic exploration of sequence space, which is not demonstrated.
- **Required correction** Either provide evidence of multiple sequence variants or rephrase the claim to reflect the specific modifications made, such as "tolerance to truncation and extensive sequence redesign."

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Context for kinetic changes
- **Affected element** Kinetic analysis
- **Evidence pointer** Abstract text; location not provided
- **Issue** The abstract notes variation in kcat and Km but does not interpret these changes in the context of the design goals. It is unclear whether the changes are beneficial, neutral, or detrimental to catalytic efficiency.
- **Required correction** Provide a brief interpretation of the kinetic changes, such as whether the redesign improved substrate binding or turnover, and relate them to the structural modifications.

## Risk / unsupported claims
- The claim that the crystal structure "closely matches" the design model is unsupported without quantitative structural metrics.
- The tenfold increase in soluble protein yield is unsupported without baseline data and quantification methods.
- The retention of high thermal stability is unsupported without specific stability measurements.
- The retention of catalytic activity in purified and whole-cell systems is unsupported without activity values or kinetic parameters.
- The term "sequence variability tolerance" implies a broader exploration than the described single truncation and single redesign, which is not supported by the abstract.